On 5m timeframe (not allowed for public ideas) Declining OBV (OBV divergence), MACD divergence, Lower volume on new highs. A correction, at least short term, seems due, even if longer term QQQ keeps going up.
Not sure if the BLUE support is gonna hold this time around. Might eventually sets on ~9yr-old support (note chart is in Log scale). Monthly chart also showing massive MACD divergence. As a result, sold my position to see how is gonna play out in the ST. Also binary outcome drug data expected this year, with unknown timing. However, INCY is top pick at Credit...
Depending on earnings annoucement, a potential downtrend might ensue with a re-test of the 23ish area, the price at which multiple insiders added to their positions in mid Dec 2017. Bullish long term. Analysts TPs between $44 and $78.
